Recently, several cationic antimicrobial peptides (CAPs), such as LTX‐315, have been extensively investigated as novel anticancer agents due to their ability to kill tumor cells and create a highly proinflammatory status of the TME, mainly via causing the destabilization of tumor cell plasma and mitochondrial membrane.12 This evidence concerns the gene CAPS and neoplasm.